Get access to prescription weight loss medication online

The Clyne membership is $99/mo and covers provider consultations, 24/7 messaging, titration management, side-effect support, and ongoing care. Medication is billed separately. Branded FDA-approved medications (Foundayo, Wegovy Pill, Zepbound) start at $149/mo. Compounded alternatives also start at $149/mo. Total cost depends on which medication your provider prescribes and whether you use insurance.

Many commercial insurance plans now cover GLP-1 medications like Wegovy, Zepbound, and Ozempic for weight management. Clyne's insurance concierge checks your coverage, submits prior authorization paperwork, and fights for approval on your behalf. If insurance covers your medication, you may only owe a copay — some patients pay as little as $25/mo through manufacturer savings cards. If coverage is denied, your provider will recommend affordable cash-pay alternatives immediately so you don't have to wait.

Clinical trial results vary by medication. In manufacturer-sponsored trials: Zepbound (tirzepatide) showed up to 22.5% body weight loss in the SURMOUNT trials. Wegovy (semaglutide) showed up to 16.9% in the STEP trials. Foundayo (orforglipron) showed up to 14.7% in Phase 3 trials. These results were achieved at the highest doses, paired with diet and exercise, in adults with obesity or overweight with weight-related conditions. Individual results vary. Your provider will set realistic expectations based on your starting weight, health history, and medication choice.

No. Wegovy, Zepbound, and Saxenda are FDA-approved specifically for chronic weight management — not just diabetes. You may qualify if you have a BMI of 30 or greater (obesity), or a BMI of 27 or greater (overweight) with at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea. Ozempic is FDA-approved for type 2 diabetes but may be prescribed off-label for weight loss at your provider's discretion.

Branded medications (Wegovy, Zepbound, Foundayo, Ozempic) are manufactured by major pharmaceutical companies (Novo Nordisk, Eli Lilly) and have been through full FDA approval including large-scale clinical trials. Compounded medications are made by FDA-registered 503B outsourcing pharmacies using the same active ingredients (semaglutide, tirzepatide) but in custom formulations. Compounded products are not individually FDA-approved but are legally prescribed by licensed providers. Clyne offers both so you have maximum choice based on your budget, insurance, and preferences.

GLP-1 medications are designed for ongoing use, similar to medications for high blood pressure or cholesterol. The biological factors that cause weight gain — appetite regulation, hormone signaling, metabolic rate — don't permanently change when you lose weight. Clinical data shows that most patients regain weight within 1–2 years of stopping GLP-1 treatment. Your provider will work with you on a long-term maintenance plan, which may include tapering to a lower dose over time or transitioning to lifestyle-focused maintenance if appropriate.

The most commonly reported side effects are gastrointestinal: nausea (most common, affects ~40% of patients initially), constipation, diarrhea, vomiting, and stomach discomfort. These are usually mild to moderate and tend to improve significantly within the first 4–8 weeks as your body adjusts. Your Clyne provider uses a slow titration schedule to minimize side effects and provides specific guidance on anti-nausea strategies, meal timing, hydration, and dietary adjustments.

Yes — this is one of Clyne's biggest advantages. We offer 6+ GLP-1 options (branded and compounded, oral and injectable) specifically so you have flexibility. If your current medication causes intolerable side effects, isn't producing results, or becomes too expensive, your provider can switch you to a different option without restarting the intake process or paying a new consultation fee. Switching is handled through a simple message to your care team.

NovoCare and LillyDirect are manufacturer fulfillment programs — they ship the medication but don't provide medical oversight. With Clyne, you get a complete weight management program: a licensed provider who prescribes and monitors your treatment, 24/7 messaging support, proactive titration management, side-effect protocols, and the ability to switch between multiple medications. Clyne also offers compounded alternatives that manufacturers don't provide, giving you more affordable options if branded medications are out of budget.

There's no video call required. You complete a detailed health questionnaire covering your medical history, current medications, weight history, BMI, goals, and preferences (pill vs injection, budget, insurance status). A board-certified provider reviews everything asynchronously — usually within 24 hours. If they need more information, they'll message you directly. If you qualify, you'll receive a prescription and next steps. If not, they'll explain why and suggest alternatives.

Yes. Clyne is fully HIPAA-compliant. Your medical information is encrypted, stored securely, and never shared with third parties for marketing purposes. Medications ship in discreet packaging with no indication of contents. Your employer, family members, or insurance company will only see what's required for claims processing (if using insurance).

Yes. Both the Clyne membership fee and all prescribed medications are eligible expenses under Flexible Spending Accounts (FSA) and Health Savings Accounts (HSA). This effectively saves you 25–35% depending on your tax bracket. You can use your FSA/HSA debit card at checkout or submit receipts for reimbursement.